AI reads CT scans to spot pancreatic cancer faster

NCT ID NCT07439757

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an artificial intelligence (AI) system that analyzes contrast-enhanced CT scans to help diagnose and manage pancreatic diseases. The AI will classify patients into three groups: needing immediate treatment, close monitoring, or routine follow-up. Researchers will compare the AI's recommendations to those of experienced doctors to see if it can improve accuracy and reduce unnecessary surgeries. The trial aims to enroll 2,000 participants with suspected pancreatic conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Artificial intelligence diagnostic system
What this could lead to
If successful, this AI could help doctors more accurately diagnose pancreatic diseases, reducing missed cancers and unnecessary surgeries.
What could go wrong
This is an early-stage study comparing AI to human experts, and the AI may not perform as well in real-world settings or with all patient types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS (AP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Changhai Hospital

    RECRUITING

    Shanghai, 200433, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.